Kewaunee SVP granted 2,717 restricted stock units

Batdorff Douglas J. reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 06/25/2026 - 04:31 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Batdorff Douglas J. reported acquisition or exercise transactions in this Form 4 filing.

Kewaunee Scientific senior vice president of manufacturing operations Douglas J. Batdorff received a grant of 2,717 restricted stock units tied to the company’s common stock. Each unit represents a right to one share. Following this grant, he holds 2,717 restricted stock units directly.

The award will vest in three equal annual installments beginning on June 30, 2027, and is contingent on his continued employment with the company. This is a compensation-related equity grant rather than an open-market stock purchase or sale.

Insider Trade Summary

Grant/Award: 2,717 shares

Grant/Award 1 txn

Insider Batdorff Douglas J.

Role SVP, Manufacturing Operations

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units FY27	2,717	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units FY27 — 2,717 contracts (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
2. F2. The restricted stock units shall vest in three equal annual installments beginning June 30, 2027, subject to the reporting person's continued employment with the Company.

Key Figures

RSUs granted: 2,717 units Shares per RSU: 1 share per unit Post-grant RSU holdings: 2,717 units +2 more

5 metrics

RSUs granted 2,717 units Restricted stock units FY27 grant to SVP

Shares per RSU 1 share per unit Each RSU equals one share of common stock

Post-grant RSU holdings 2,717 units Total restricted stock units held directly after grant

Vesting start date June 30, 2027 First installment of three equal annual vesting tranches

Vesting structure 3 equal annual installments RSUs vest over three years beginning June 30, 2027

Key Terms

Restricted Stock Units, contingent right, vest, continued employment

4 terms

Restricted Stock Units financial

"Each restricted stock unit represents a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"represents a contingent right to receive one share of the Company's common stock"

vest financial

"The restricted stock units shall vest in three equal annual installments"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

continued employment financial

"subject to the reporting person's continued employment with the Company"

Continued employment means that an individual remains in their current job without interruption. For investors, it signals stability and ongoing work that can affect company performance and future prospects. Like a steady heartbeat for a business, sustained employment helps ensure consistent operations and financial health.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did KEQU’s Douglas J. Batdorff report on this Form 4?

Douglas J. Batdorff reported receiving 2,717 restricted stock units as equity compensation. These RSUs are tied to Kewaunee Scientific’s common stock and represent a contingent right to receive one share for each unit, subject to future vesting conditions.

How many Kewaunee Scientific (KEQU) restricted stock units were granted to Douglas J. Batdorff?

He was granted 2,717 restricted stock units. Each unit represents a contingent right to receive one share of Kewaunee Scientific common stock, giving him 2,717 units directly following the transaction, all subject to the specified vesting schedule and employment conditions.

When do the KEQU restricted stock units granted to Douglas J. Batdorff begin vesting?

The restricted stock units begin vesting on June 30, 2027. Vesting occurs in three equal annual installments starting on that date, and each installment depends on Batdorff’s continued employment with Kewaunee Scientific through the applicable vesting dates.

What does each Kewaunee Scientific (KEQU) restricted stock unit represent in this Form 4?

Each restricted stock unit represents a contingent right to receive one share of Kewaunee Scientific common stock. The units convert into actual shares only as they vest over time, subject to the continued employment requirement described in the filing footnotes.

Is the KEQU Form 4 transaction an open-market buy or sell of shares?

No, the transaction is a grant of restricted stock units, not an open-market trade. The Form 4 shows a compensation-related award coded as an acquisition, with no purchase price and vesting over future years instead of immediate stock buying or selling.

What employment condition is attached to Douglas J. Batdorff’s KEQU restricted stock units?

The restricted stock units vest only if Batdorff continues his employment with Kewaunee Scientific. Vesting occurs in three equal annual installments beginning June 30, 2027, making ongoing service a key requirement for receiving the underlying common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Batdorff Douglas J.

(Last) (First) (Middle)

2700 WEST FRONT STREET

(Street)

STATESVILLE NORTH CAROLINA 28677

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KEWAUNEE SCIENTIFIC CORP /DE/ [ KEQU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Manufacturing Operations

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units FY27	(1)	06/24/2026		A		2,717		(2)	(2)	Common Stock	2,717	$0	2,717	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

2. The restricted stock units shall vest in three equal annual installments beginning June 30, 2027, subject to the reporting person's continued employment with the Company.

Remarks:

	/s/ Donald T. Gardner III, Attorney-in-fact	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)